Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kenetik
- Development stage
- Unknown
- Lead developer
- VitaNav
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Kenetik is an exogenous ketone supplement developed by VitaNav. It is a non-salt ketone beverage containing a patented blend of bioidentical D-beta-hydroxybutyrate (D-BHB) and R-1,3-butanediol, a ketone precursor that is metabolized in the liver to extend ketone elevation. Kenetik is designed to induce rapid, sustained nutritional ketosis without the need for a strict ketogenic diet or fasting, providing a clean energy source for the brain and body. It is being investigated in clinical trials (such as Phase 2/3 studies) for the management of alcohol use disorder (AUD) and alcohol withdrawal symptoms, as well as for its effects on brain metabolism and cognitive performance.
- Brand names
- Kenetik
- Other names
- 1,3-butanediol and D-hydroxybutyric acidD-beta-hydroxybutyrate + R-1,3-butanediolD-beta-hydroxybutyrate and R-1,3-butanediolD-beta-hydroxybutyric acid and R-1,3-butanediolD-beta-hydroxybutyric acid with R-1,3-butanediolKenetik Ketone DrinkKenetik: Ketone Drink
02
Targets
HDAC2 (Histone deacetylase 2)HDAC3 (Histone Deacetylase 3)HCAR2 (Hydroxycarboxylic acid receptor 2)NLRP3 (Nod-like receptor family pyrin domain-containing protein 3)
Beyond the preview
Go deeper on Kenetik.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kenetik.